Papagudi G. Subramanian

Development of a cost‐effective ‘duplexed’ real‐time PCR assay for minimal residual disease monitoring of chronic myeloid leukemia using locked nucleic acid probes

H. Doshi, S. Gujral, P. Tembhare, 2016, International journal of laboratory hematology.

Transient abnormal myelopoiesis: A case series and review of the literature

S. Gujral, P. Subramanian, B. Arora, 2017 .

15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges

G. Chatterjee, S. Gujral, P. Tembhare, 2023, European journal of haematology.